Loading...

LakeShore Biopharma Co., Ltd.

LSBPWNASDAQ
Healthcare
Biotechnology
$0.03
$-0.00(-5.19%)

LakeShore Biopharma Co., Ltd. (LSBPW) Company Profile & Overview

Explore LakeShore Biopharma Co., Ltd.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

LakeShore Biopharma Co., Ltd. (LSBPW) Company Profile & Overview

LakeShore Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.

SectorHealthcare
IndustryBiotechnology
CEOWang Xu

Contact Information

86 10 8920 2086
Building No. 2, Beijing, 102629

Company Facts

758 Employees
CountryCN
Actively Trading

Frequently Asked Questions

;